Issue 37, 2019

Design and synthesis of novel phenylaminopyrimidines with antiproliferative activity against colorectal cancer

Abstract

New phenylaminopyrimidine (PAP) derivatives have been designed and synthesised as potential tyrosine kinase inhibitors for the treatment of cancer. The synthesized compounds share a general structure and vary in the substitution pattern at position-2 of the pyridine ring. Several derivatives have demonstrated potent anticancer activities against HCT-116, HT-29 and LS-174T colorectal cancer cells. Furthermore, a number of hits showed good selectivity to Src-kinase. The cytotoxic mechanisms of these compounds were also investigated by studying their effects on cell-cycle distribution. Among all the compounds examined, compound 8b (with a terminal pyridin-3-yl moiety at the pyridine ring) showed the highest inhibitory selectivity towards src-kinase, which was coupled with cell cycle arrest, and apoptotic and autophagic interference, in colorectal cancer cells. This report introduces a novel category of PAP derivatives with promising kinase inhibitory and anticancer effects against colon cancer.

Graphical abstract: Design and synthesis of novel phenylaminopyrimidines with antiproliferative activity against colorectal cancer

Supplementary files

Article information

Article type
Paper
Submitted
05 May 2019
Accepted
04 Jul 2019
First published
11 Jul 2019
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2019,9, 21578-21586

Design and synthesis of novel phenylaminopyrimidines with antiproliferative activity against colorectal cancer

H. A. Henidi, A. M. Al-Abd, F. A. Al-Abbasi, H. A. BinMahfouz and I. M. El-Deeb, RSC Adv., 2019, 9, 21578 DOI: 10.1039/C9RA03359A

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements